Last Price | 67.62 | Max Price | 99.95 |
Min Price | 67.62 | 1 Year return | -32.74 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 47 | 2,019,627 | 0.00 % |
2020 | 42 | 2,170,562 | 0.00 % |
2021 | 49 | 2,404,921 | 0.00 % |
2022 | 52 | 2,645,840 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
Utah Medical Products mainly operates in the pharmaceutical sector. Over the past 10 years the global pharmaceutical companies gained around 75 percent. Over the past 5 years the sector is 147 percent higher.
The period between December 2015 and December 2016 was a profitable period for the investors in Utah Medical Products. The stock gained around 26 percent. Over the period from December 2011 till December 2016 the stock rose on average 156 percent. Utah Medical Products's revenues between 2011 and 2015 were quite similar and moved between 41,55 million dollars and 40,16 million dollars. Utah Medical Products's net incomes between 2011 and 2015 were very volatile and moved between 7,42 million dollars and 11,84 million dollars.
Over the past 5 years the American company paid out dividends. Over the past 5 years Utah Medical Products's dividend yield was at around 4,95 percent per year.
At the end of 2015 the American company's balance sheet was worth 79,18 million dollars. The total debt was around 9,53 million dollars. This is 12,04 percent of the total balance sheet. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio 19. So the stock' value was 19 times the 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 217,39 million dollars. At the end of 2015 the American company had around 3,75 million stocks listed on the exchanges.
All the company's financial reports are available here. More information about Utah Medical Products can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
40
|
39
|
41
|
42
|
47
|
42
|
Costs |
28
|
27
|
33
|
23
|
32
|
31
|
Profit |
12
|
12
|
9
|
19
|
15
|
11
|
Margin of profit |
29.48
|
30.87
|
20.55
|
44.19
|
31.41
|
25.60
|
ROI |
17.00
|
17.52
|
10.89
|
20.86
|
14.57
|
10.50
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
70
|
69
|
78
|
89
|
101
|
103
|
Debt |
10
|
7
|
15
|
11
|
9
|
9
|
Total assets |
79
|
76
|
93
|
100
|
110
|
112
|
Solvency |
87.96
|
90.88
|
84.23
|
89.20
|
92.08
|
92.01
|
Cash |
23
|
26
|
40
|
51
|
43
|
52
|
Cashflow |
14
|
15
|
17
|
17
|
17
|
20
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
1.45
|
2.09
|
1.16
|
1.56
|
1.96
|
2.26
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
57.49
|
71.44
|
79.93
|
81.58
|
105.96
|
Eps |
3.22
|
2.28
|
4.95
|
3.94
|
2.94
|
Price/earnings-ratio |
17.85
|
31.33
|
16.15
|
20.71
|
23.00
|
Dividend |
1.05
|
1.07
|
1.09
|
1.11
|
1.13
|
Dividend % |
1.83 %
|
1.50 %
|
1.36 %
|
1.36 %
|
1.67 %
|
Payout % |
0.33
|
0.47
|
0.22
|
0.28
|
0.38
|
Book value |
18.61
|
20.99
|
23.92
|
27.16
|
28.22
|
Market to book |
0.32
|
0.29
|
0.30
|
0.33
|
0.42
|
Cashflow per stock |
3.90
|
4.54
|
4.52
|
4.58
|
5.53
|
Stocks |
4
|
4
|
4
|
4
|
4
|
Market Cap |
213.92
|
265.83
|
297.34
|
303.64
|
246.34
|
Date
|
Price
|
---|---|
22 Apr 2024
|
67.62
|
18 Apr 2024
|
67.62
|
17 Apr 2024
|
68.12
|
09 Apr 2024
|
70.00
|
05 Apr 2024
|
68.55
|
03 Apr 2024
|
69.38
|
30 Mar 2024
|
71.11
|
22 Mar 2024
|
68.53
|
18 Mar 2024
|
69.27
|
15 Mar 2024
|
69.63
|
12 Mar 2024
|
69.80
|
11 Mar 2024
|
69.31
|
09 Mar 2024
|
69.31
|
07 Mar 2024
|
69.31
|
01 Mar 2024
|
70.18
|
29 Feb 2024
|
69.90
|
27 Feb 2024
|
70.50
|
22 Feb 2024
|
71.55
|
21 Feb 2024
|
72.76
|
20 Feb 2024
|
72.40
|
15 Feb 2024
|
71.28
|
14 Feb 2024
|
71.28
|
13 Feb 2024
|
75.00
|
09 Feb 2024
|
74.18
|
08 Feb 2024
|
73.93
|
07 Feb 2024
|
74.94
|
06 Feb 2024
|
74.16
|
05 Feb 2024
|
76.98
|
01 Feb 2024
|
79.21
|
31 Jan 2024
|
80.40
|